FTA Drug & Alcohol Program National Conference
April 14 - April 16
FTA Drug & Alcohol Program National Conference
Save the date for the 19th Annual FTA Drug and Alcohol Program National Conference on April 14–16, 2026 in Portland, OR.
The annual conference is designed for Drug and Alcohol Program Managers and other transit officials. The workshop will offer sessions to foster a better understanding of the FTA Prevention of Alcohol Misuse and Prohibited Drug Use in Transit Operations (49 CFR Part 655) and USDOT Procedures for Transportation Workplace Drug and Alcohol Testing Programs (49 CFR Part 40).
The conference is free of charge, and registration will open in March 2026. Check FTA’s Drug and Alcohol Program web page for further updates.
Location: Portland, OR
Provider: Federal Transit Administration (FTA)
Intended for: FTA DERs and DER Alternates
NOTICE OF NONDISCRIMINATION The Arkansas Transit Association complies with all civil rights provisions of federal statutes and related authorities that prohibit discrimination in programs and activities receiving federal financial assistance. Therefore, the Arkansas Transit Association does not discriminate on the basis of race, sex, color, age, national origin, religion or disability, Limited English Proficiency (LEP), or low-income status in the admission, access to and treatment in the Arkansas Transit Association 's programs and activities, as well as the Arkansas Transit Association 's hiring or employment practices. Complaints of alleged discrimination and inquiries regarding the Arkansas Transit Association 's nondiscrimination policies may be directed to Ann H. Gilbert (Title VI ADA/504 Coordinator), 620 W. Broadway St., North Little Rock, AR 72114, 501-372-8900, (Voice/TTY 711), or the following email address: info@arktransit.org or Ann H. Gilbert (Title VI ADA/504 Coordinator), agilbert@arktransit.org. Free language assistance for Limited English Proficient individuals is available upon request. This notice is available from the Title VI ADA/504 Coordinator in large print, on audiotape and in Braille.